Early Diagnosis of Oral Cancer by Detecting p16 Methylation

NCT01695018 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2014-09-25

No results posted yet for this study

Summary

The purpose of this study is to verify the function of p16 methylation diagnostic reagents in early diagnosis of oral cancer.

Conditions

  • Moderate Epithelial Dysplasia
  • Mild Epithelial Dysplasia

Sponsors & Collaborators

  • Peking University

    lead OTHER

Principal Investigators

  • Dajun Deng, MD · Peking University

Eligibility

Min Age
25 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2014-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01695018 on ClinicalTrials.gov